Medical Cannabis for Autism Spectrum Disorder — Switzerland 2026

In ASD with severe behavioural symptoms, CBD-rich cannabis extracts are one of the few options with published cohort data. Affordable for members.

In ASD, CBD-rich cannabis oil (CBD:THC ~20:1) reduces (Israeli cohorts Aran 2019, Bar-Lev 2019, n=188) aggression, self-injury, tantrums and sleep problems in 60–80 % of children and adolescents. First line remains behavioural therapy and possibly risperidone; cannabis as off-label option in resistance. CannabisClub members: 50 CHF flat instead of 190.

What the studies show

Aran 2019 (cohort, n=60): CBD-rich oil 20:1 over 7 months — 61 % marked behavioural improvement, 39 % better sleep.

Bar-Lev Schleider 2019 (n=188): 30 % strong, 53 % moderate improvement; core issues aggression and self-injury.

Preparations & dosing

Full-spectrum CBD-rich oil (ratio CBD:THC ~20:1 to 40:1): start 1 mg/kg CBD, slow titration to 5–10 mg/kg CBD.

Split into 3 daily doses, slight evening increase for sleep issues.

Save as a CannabisClub member

Autism cannabis therapy needs close follow-up and dose adjustments. External consult 190 CHF, member 50 CHF flat — quarterly 560 CHF/year saved.

Registration free.

FAQ

Does cannabis change core ASD?

No. It reduces associated symptoms (aggression, self-injury, anxiety, sleep) — not the neurodivergent core. Goal: quality of life, not 'cure'.

What does membership save?

50 CHF instead of 190 CHF per consult. Quarterly 560 CHF/year. Registration free.

Does insurance cover cannabis for autism?

Possible in severe resistant ASD with dangerous self-injury, Art. 71a HIO agreement. Israeli data helps the application.

Cannabis for Autism Spectrum Disorder — CBD & Prescription Switzerland 2026 (Members 50 CHF)